Logo image of WOOF

PETCO HEALTH AND WELLNESS CO (WOOF) Stock Fundamental Analysis

NASDAQ:WOOF - Nasdaq - US71601V1052 - Common Stock - Currency: USD

2.97  -0.1 (-3.26%)

After market: 2.95 -0.02 (-0.67%)

Fundamental Rating

2

WOOF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. WOOF has a bad profitability rating. Also its financial health evaluation is rather negative. WOOF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year WOOF has reported negative net income.
WOOF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: WOOF reported negative net income in multiple years.
In the past 5 years WOOF always reported a positive cash flow from operatings.
WOOF Yearly Net Income VS EBIT VS OCF VS FCFWOOF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

The Return On Assets of WOOF (-1.31%) is comparable to the rest of the industry.
WOOF has a Return On Equity (-6.05%) which is in line with its industry peers.
With a Return On Invested Capital value of 0.79%, WOOF perfoms like the industry average, outperforming 41.32% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for WOOF is significantly below the industry average of 13.07%.
Industry RankSector Rank
ROA -1.31%
ROE -6.05%
ROIC 0.79%
ROA(3y)-8.15%
ROA(5y)-4.47%
ROE(3y)-37.81%
ROE(5y)-21.49%
ROIC(3y)1.45%
ROIC(5y)2.27%
WOOF Yearly ROA, ROE, ROICWOOF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Operating Margin, with a value of 0.66%, WOOF is in line with its industry, outperforming 40.50% of the companies in the same industry.
WOOF's Operating Margin has declined in the last couple of years.
WOOF has a Gross Margin of 38.08%. This is comparable to the rest of the industry: WOOF outperforms 56.20% of its industry peers.
WOOF's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.66%
PM (TTM) N/A
GM 38.08%
OM growth 3Y-62.42%
OM growth 5Y-38.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-2.44%
WOOF Yearly Profit, Operating, Gross MarginsWOOF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WOOF is destroying value.
WOOF has more shares outstanding than it did 1 year ago.
WOOF has more shares outstanding than it did 5 years ago.
WOOF has a worse debt/assets ratio than last year.
WOOF Yearly Shares OutstandingWOOF Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
WOOF Yearly Total Debt VS Total AssetsWOOF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that WOOF is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WOOF (1.00) is worse than 71.90% of its industry peers.
The Debt to FCF ratio of WOOF is 33.81, which is on the high side as it means it would take WOOF, 33.81 years of fcf income to pay off all of its debts.
WOOF has a Debt to FCF ratio of 33.81. This is comparable to the rest of the industry: WOOF outperforms 48.76% of its industry peers.
A Debt/Equity ratio of 1.43 is on the high side and indicates that WOOF has dependencies on debt financing.
WOOF has a Debt to Equity ratio of 1.43. This is in the lower half of the industry: WOOF underperforms 62.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 33.81
Altman-Z 1
ROIC/WACC0.08
WACC10.25%
WOOF Yearly LT Debt VS Equity VS FCFWOOF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 0.85 indicates that WOOF may have some problems paying its short term obligations.
WOOF has a Current ratio of 0.85. This is amonst the worse of the industry: WOOF underperforms 83.47% of its industry peers.
WOOF has a Quick Ratio of 0.85. This is a bad value and indicates that WOOF is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of WOOF (0.25) is worse than 80.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.25
WOOF Yearly Current Assets VS Current LiabilitesWOOF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

WOOF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.00%.
WOOF shows a decrease in Revenue. In the last year, the revenue decreased by -2.37%.
The Revenue has been growing slightly by 6.64% on average over the past years.
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y1.75%
Revenue growth 5Y6.64%
Sales Q2Q%-2.34%

3.2 Future

The Earnings Per Share is expected to grow by 55.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 0.30% on average over the next years.
EPS Next Y271.1%
EPS Next 2Y129.49%
EPS Next 3Y73.65%
EPS Next 5Y55.44%
Revenue Next Year-2.19%
Revenue Next 2Y-0.41%
Revenue Next 3Y0.46%
Revenue Next 5Y0.3%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WOOF Yearly Revenue VS EstimatesWOOF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
WOOF Yearly EPS VS EstimatesWOOF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

WOOF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
WOOF is valuated correctly with a Price/Forward Earnings ratio of 14.66.
Based on the Price/Forward Earnings ratio, WOOF is valued a bit cheaper than the industry average as 66.94% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of WOOF to the average of the S&P500 Index (21.76), we can say WOOF is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.66
WOOF Price Earnings VS Forward Price EarningsWOOF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WOOF is valued a bit cheaper than the industry average as 60.33% of the companies are valued more expensively.
WOOF's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. WOOF is cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.97
EV/EBITDA 10.09
WOOF Per share dataWOOF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WOOF's earnings are expected to grow with 73.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y129.49%
EPS Next 3Y73.65%

0

5. Dividend

5.1 Amount

No dividends for WOOF!.
Industry RankSector Rank
Dividend Yield N/A

PETCO HEALTH AND WELLNESS CO

NASDAQ:WOOF (7/11/2025, 8:00:02 PM)

After market: 2.95 -0.02 (-0.67%)

2.97

-0.1 (-3.26%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-05 2025-06-05/amc
Earnings (Next)09-08 2025-09-08/bmo
Inst Owners67.69%
Inst Owner Change0%
Ins Owners4.1%
Ins Owner Change28.74%
Market Cap935.94M
Analysts69.41
Price Target3.95 (33%)
Short Float %33.9%
Short Ratio5.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)136.57%
Min EPS beat(2)118.13%
Max EPS beat(2)155.02%
EPS beat(4)4
Avg EPS beat(4)84.01%
Min EPS beat(4)15.3%
Max EPS beat(4)155.02%
EPS beat(8)7
Avg EPS beat(8)8.16%
EPS beat(12)9
Avg EPS beat(12)5.28%
EPS beat(16)13
Avg EPS beat(16)7.06%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-2.5%
Max Revenue beat(2)-2.39%
Revenue beat(4)0
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-2.5%
Max Revenue beat(4)-1.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.54%
Revenue beat(12)2
Avg Revenue beat(12)-1.47%
Revenue beat(16)4
Avg Revenue beat(16)-0.82%
PT rev (1m)1.29%
PT rev (3m)2.99%
EPS NQ rev (1m)11.99%
EPS NQ rev (3m)88.89%
EPS NY rev (1m)0%
EPS NY rev (3m)125.21%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-4.87%
Revenue NY rev (1m)-0.36%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.66
P/S 0.15
P/FCF 19.97
P/OCF 5.49
P/B 0.85
P/tB N/A
EV/EBITDA 10.09
EPS(TTM)-0.01
EYN/A
EPS(NY)0.2
Fwd EY6.82%
FCF(TTM)0.15
FCFY5.01%
OCF(TTM)0.54
OCFY18.23%
SpS19.3
BVpS3.51
TBVpS-2.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.31%
ROE -6.05%
ROCE 1%
ROIC 0.79%
ROICexc 0.81%
ROICexgc 1.67%
OM 0.66%
PM (TTM) N/A
GM 38.08%
FCFM 0.77%
ROA(3y)-8.15%
ROA(5y)-4.47%
ROE(3y)-37.81%
ROE(5y)-21.49%
ROIC(3y)1.45%
ROIC(5y)2.27%
ROICexc(3y)1.5%
ROICexc(5y)2.35%
ROICexgc(3y)3.54%
ROICexgc(5y)5.94%
ROCE(3y)1.84%
ROCE(5y)2.88%
ROICexcg growth 3Y-60.84%
ROICexcg growth 5Y-33.82%
ROICexc growth 3Y-57.79%
ROICexc growth 5Y-30.5%
OM growth 3Y-62.42%
OM growth 5Y-38.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-2.44%
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF 33.81
Debt/EBITDA 6.59
Cap/Depr 62.03%
Cap/Sales 2.04%
Interest Coverage 0.3
Cash Conversion 71.19%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.25
Altman-Z 1
F-Score6
WACC10.25%
ROIC/WACC0.08
Cap/Depr(3y)106.63%
Cap/Depr(5y)109.98%
Cap/Sales(3y)3.43%
Cap/Sales(5y)3.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%125%
EPS Next Y271.1%
EPS Next 2Y129.49%
EPS Next 3Y73.65%
EPS Next 5Y55.44%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y1.75%
Revenue growth 5Y6.64%
Sales Q2Q%-2.34%
Revenue Next Year-2.19%
Revenue Next 2Y-0.41%
Revenue Next 3Y0.46%
Revenue Next 5Y0.3%
EBIT growth 1Y1905.57%
EBIT growth 3Y-61.76%
EBIT growth 5Y-34.33%
EBIT Next Year286.43%
EBIT Next 3Y65.32%
EBIT Next 5Y36.54%
FCF growth 1Y-9.86%
FCF growth 3Y-25.28%
FCF growth 5YN/A
OCF growth 1Y-47.69%
OCF growth 3Y-20.84%
OCF growth 5Y10%